A landscape for drug-target interactions based on network analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
31
07
2020
accepted:
30
01
2021
entrez:
17
3
2021
pubmed:
18
3
2021
medline:
26
8
2021
Statut:
epublish
Résumé
In this work, we performed an analysis of the networks of interactions between drugs and their targets to assess how connected the compounds are. For our purpose, the interactions were downloaded from the DrugBank database, and we considered all drugs approved by the FDA. Based on topological analysis of this interaction network, we obtained information on degree, clustering coefficient, connected components, and centrality of these interactions. We identified that this drug-target interaction network cannot be divided into two disjoint and independent sets, i.e., it is not bipartite. In addition, the connectivity or associations between every pair of nodes identified that the drug-target network is constituted of 165 connected components, where one giant component contains 4376 interactions that represent 89.99% of all the elements. In this regard, the histamine H1 receptor, which belongs to the family of rhodopsin-like G-protein-coupled receptors and is activated by the biogenic amine histamine, was found to be the most important node in the centrality of input-degrees. In the case of centrality of output-degrees, fostamatinib was found to be the most important node, as this drug interacts with 300 different targets, including arachidonate 5-lipoxygenase or ALOX5, expressed on cells primarily involved in regulation of immune responses. The top 10 hubs interacted with 33% of the target genes. Fostamatinib stands out because it is used for the treatment of chronic immune thrombocytopenia in adults. Finally, 187 highly connected sets of nodes, structured in communities, were also identified. Indeed, the largest communities have more than 400 elements and are related to metabolic diseases, psychiatric disorders and cancer. Our results demonstrate the possibilities to explore these compounds and their targets to improve drug repositioning and contend against emergent diseases.
Identifiants
pubmed: 33730052
doi: 10.1371/journal.pone.0247018
pii: PONE-D-20-23927
pmc: PMC7968663
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0247018Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Comput Math Methods Med. 2015;2015:130620
pubmed: 25969690
Nat Chem Biol. 2008 Nov;4(11):682-90
pubmed: 18936753
J Virol. 2016 Sep 12;90(19):8924-33
pubmed: 27466418
Nature. 2020 Jun;582(7813):469
pubmed: 32546811
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1118-23
pubmed: 18216267
Drug Discov Today. 2010 Jul;15(13-14):517-30
pubmed: 20553955
Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Sep;76(3 Pt 2):036106
pubmed: 17930305
J Med Chem. 2014 May 8;57(9):3856-73
pubmed: 24779514
Curr Opin Cell Biol. 2003 Apr;15(2):241-6
pubmed: 12648681
Mol Inform. 2010 Jan 12;29(1-2):10-4
pubmed: 27463845
Clin Pharmacol Ther. 2010 Jul;88(1):120-5
pubmed: 20520604
J Neurochem. 2010 May;113(3):563-75
pubmed: 20089135
Drug Metab Pharmacokinet. 2009;24(4):308-17
pubmed: 19745558
Biochem J. 1999 Nov 15;344 Pt 1:253-8
pubmed: 10548558
Fundam Clin Pharmacol. 2015 Apr;29(2):131-49
pubmed: 25659970
Cell. 2017 Jan 26;168(3):377-389.e12
pubmed: 28129538
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Drug Discov Today. 2015 Mar;20(3):318-31
pubmed: 25448759
Res Vet Sci. 2005 Oct;79(2):113-23
pubmed: 15924928
Nat Rev Drug Discov. 2017 May;16(5):309-310
pubmed: 28280260
Nat Rev Genet. 2004 Feb;5(2):101-13
pubmed: 14735121
Nucleic Acids Res. 2009 Jan;37(Database issue):D211-5
pubmed: 18940856
Nat Rev Drug Discov. 2004 Aug;3(8):711-5
pubmed: 15286737
Nat Rev Drug Discov. 2006 Oct;5(10):821-34
pubmed: 17016423
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7821-6
pubmed: 12060727
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2658-63
pubmed: 14981240
Brief Bioinform. 2020 Jan 17;21(1):47-61
pubmed: 30325405
J R Soc Interface. 2013 Dec 18;11(92):20131057
pubmed: 24352679
Neuroscience. 2010 Sep 1;169(3):1007-16
pubmed: 20576498
Biochemistry. 2006 Jul 18;45(28):8527-38
pubmed: 16834326
Alcohol Alcohol. 1998 Jul-Aug;33(4):317-36
pubmed: 9719389
Nat Rev Drug Discov. 2010 Mar;9(3):203-14
pubmed: 20168317
J Pharmacol Exp Ther. 2006 Dec;319(3):998-1008
pubmed: 16946104
Am J Hematol. 2018 Jul;93(7):921-930
pubmed: 29696684
Mol Biosyst. 2009 Dec;5(12):1536-48
pubmed: 19763339
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Feb;69(2 Pt 2):026113
pubmed: 14995526
J Cheminform. 2015 Feb 26;7:7
pubmed: 25741385
Neuropsychopharmacology. 2019 May;44(6):1123-1131
pubmed: 30733568
Immunotherapy. 2018 Jan;10(1):9-25
pubmed: 28967793
Biochem J. 1994 Mar 1;298 ( Pt 2):249-58
pubmed: 7510950
Nat Rev Drug Discov. 2006 Dec;5(12):993-6
pubmed: 17139284
PLoS One. 2013 May 07;8(5):e62975
pubmed: 23667553
Nutr Rev. 2009 Nov;67(11):658-72
pubmed: 19906252
Front Pharmacol. 2018 Oct 09;9:1134
pubmed: 30356768
Cell Rep. 2015 Feb 3;10(4):600-15
pubmed: 25640182
Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Jul;74(1 Pt 2):016110
pubmed: 16907154
Sci Rep. 2016 Aug 01;6:30750
pubmed: 27476470
J Med Chem. 2014 Oct 9;57(19):7874-87
pubmed: 24946140
J Trace Elem Med Biol. 2016 May;35:107-15
pubmed: 27049134
Nat Biotechnol. 2012 Nov;30(11):1125-30
pubmed: 23064238
Adv Nutr. 2019 Jul 1;10(4):696-710
pubmed: 31305906
Nucleic Acids Res. 2009 Jan;37(Database issue):D680-5
pubmed: 18948278
Schizophr Bull. 2014 Mar;40(2):327-40
pubmed: 23328157
Science. 2015 Feb 20;347(6224):1257601
pubmed: 25700523
Br J Pharmacol. 2014 May;171(9):2308-20
pubmed: 24329544
Int J Antimicrob Agents. 2016 Oct;48(4):349-52
pubmed: 27546219
BMC Bioinformatics. 2019 Dec 16;20(Suppl 26):628
pubmed: 31839008
Mol Biosyst. 2012 Jul 6;8(7):1970-8
pubmed: 22538619
Brief Bioinform. 2016 Jul;17(4):696-712
pubmed: 26283676
Expert Opin Drug Discov. 2016;11(3):225-39
pubmed: 26814169
Science. 2000 Mar 17;287(5460):1960-4
pubmed: 10720314
Expert Opin Ther Targets. 2007 May;11(5):695-705
pubmed: 17465726
Nat Biotechnol. 2007 Oct;25(10):1119-26
pubmed: 17921997
Trends Microbiol. 2018 Oct;26(10):865-876
pubmed: 29759926
Nat Biotechnol. 2014 Dec;32(12):1213-22
pubmed: 25419740
Mol Biosyst. 2013 Jun;9(6):1268-81
pubmed: 23493874
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Br J Haematol. 2000 Jan;108(1):13-8
pubmed: 10651719
Mol Neurobiol. 2018 Oct;55(10):8059-8070
pubmed: 29498008